TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean change in Visual Analog Scale (VAS) Anxiety Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Hemoglobin A or Hemoglobin Level per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Serum Iron Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in score on the WHODAS 2.0
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in Shirom-Melamed Burnout Measure (SMBM)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Perceived Stress Scale (PSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Nursing Student Competence Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported use of environmental fall prevention interventions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ASES
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: iHOT-12
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mHHS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Accuracy in the diagnosis of referral retinal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stenosis index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Withdrawal rate due to major / serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Positivity of BUDAPEST CRITERIA for diagnosis of CRPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic crestal bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titer (GMT) of Serum Neutralization of Mpox Virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Solicited Adverse Events through Day 14 Post-Vaccinations
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Adverse Events that Occur within 28 Days After Final Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Atrial Myopathy Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of breakthrough blood stage infection
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of related grade 3 solicited and unsolicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of related grade 3 abnormal laboratory values
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Participant Subjective Sleep Quality (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Participant total sleep time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Participant Depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Responder rate of YVOIRE volume plus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Tongue thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tongue volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral parapharyngeal wall thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Critical respiratory events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of marginal failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Hoarseness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the milk concentration-time curve during a dosing interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed milk concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average milk concentration at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Countermovent jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal muscle inflammatory cell infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Change in Insomnia Severity Index (ISI) score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Clinical success/survival
Endpoint domain: Mortality/survival
Primary endpoint: Isometric mid-thigh pull strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of intervention
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of intervention
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Appropriateness of intervention
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence of CMV infection or disease during prophylaxis
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of CMV infection or disease in the 3 months following completion of prophylaxis
Endpoint domain: Adverse events/effects
Primary endpoint: Esophagogastroduodenoscopy (EGD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions of using the e-cigarette
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions of switching completely to the e-cigarette
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 3-Year disease-free survival (DFS) Rate
Endpoint domain: Mortality/survival
Primary endpoint: Proportion with positive index test result among participants with tuberculosis (TB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion with negative index test result among participants without tuberculosis (TB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of root caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Number of vaccinated patients who test positive for SARS-CoV-2
Endpoint domain: Adverse events/effects
Primary endpoint: Number of unvaccinated patients who test positive for SARS-CoV-2
Endpoint domain: Adverse events/effects
Primary endpoint: Number of vaccinated patients who test negative for SARS-CoV-2
Endpoint domain: Adverse events/effects
Primary endpoint: Number of unvaccinated patients who test negative for SARS-CoV-2
Endpoint domain: Adverse events/effects
Primary endpoint: Neurogenic bowel dysfunction score (NBD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Episodes of incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of bowel movements per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: adequate lung function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in the intensity of dry eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of Coenzyme Q10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of Surgical Guides in implant placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Level of free triiodothyronine (FT3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: specificity and sensitivity of blood fluorescence intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microvascular hypoperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Score of the Spinal Cord Injury - Spasticity Evaluation Tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score from the adapted Penn Spasm Frequency Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-evaluation of limitation in daily life due to spasticity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Differentiation between AVNRT and orthodromic AVRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Volume of expressed breastmilk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Thyroid Stimulating Hormone Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Having serum T4 Levels within the normal range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in medication adherence rate for patients with thyroid disorders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pulmonary nodule growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary nodule regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hand dynamometer and pinchmeter measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Undetectable viral load at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: [¹⁸F] FEPPA Binding in Selected Brain Regions of Interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time Spent Post-discharge by Discharge SAC/VAL Prescription Status
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Brief Psychiatric Rating Scale (BPRS) Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MATRICS™ Consensus Cognitive Battery (MCCB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle of trunk rotation (ATR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average core temperature during work-rest allocations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate at initial stay time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orthostatic Intolerance Symptoms Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of non-baseline cholera infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Dermatology Quality of Life Index (DLQI scores)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient Health Questionnaire (PHQ9)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in daily duration in sedentary posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-minutes Delta CO%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceptual body image dissatisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients by RAASi optimisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients by RAASi dose modification following hyperkalaemic episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of percentage of patients with RAASi treatment optimisation between patiromer treated and untreated patients following hyperkalaemic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Vitamin D in serum and follicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Level of BMP-15 in follicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and percentage of subjects with treatment emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of subjects with serious adverse event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of subjects who discontinued due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Placebo-corrected, baseline-adjusted QTc interval (ΔΔQTc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQ SSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 90-day Cryptococcal Meningitis related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Objective Response (Complete or Partial Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in STAI-Y1 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Level of awareness to oral cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of changes in ANI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Immediate Technical Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of The immediate technical failure (ITF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of LBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocyte p-S6 content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pathological complete remission (pCR) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of oxytocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: MCCB Global Cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: BDNF levels in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vagal tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in parasympathetic nervous system response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Presence of Culture Positive Vaginal Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Reach Complete Amyloid Plaque Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: intraoperative incidental injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Feeling of professional efficiency
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Skeletal muscle mitochondrial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in SARA Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants retained at 12-months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety and tolerability of MOv18 IgE
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) or maximum administered dose (MAD) of MOv18 IgE
Endpoint domain: Adverse events/effects
Primary endpoint: Anti-tumour activity of MOv18 IgE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Relative reduction of Ki67 in tumor samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Obstetric and perinatal complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in Mood States (Quality of Life)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gut Microbiome Composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gut Microbiome Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of specific mRNA for the E5 oncoprotein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Stroke size of handwriting characters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady state concentrations of tenofovir-diphosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady state concentrations of tenofovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum glycated haemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum interleukin-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum interleukin-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum tumour necrosis factor alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: shearwave elastography of the placenta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visceral fat loss (cm3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of participants who complete the narrative medicine sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in well-being scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with pain change of 30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with pain change of 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative change in pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Th17 cytokines in skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diffusion length of ropivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Severity of Alopecia Tool (SALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pain as measured by the Numeric Pain Rating Scale (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain as measured by the Wong-Baker Face Pain Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatiotemporal Gait Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve over 1 dosing interval (AUC (TAU))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of pro-inflammatory cytokines and chemokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of Achieving Minimal Residual Disease (MRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Depression at 8 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Anxiety at 8 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bile culture positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Phenotypical antibiogram resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Progesterone levels in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Premenstrual syndrome score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prediction of methotrexate related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Prediction of acute kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Baseline left ventricular (LV) systolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Baseline LV diastolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-exercise LV systolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Good functional recovery (mRS ≤ 2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Buprenorphine retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Caffeine Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of Distribution of Caffeine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative culture conversion until 8 weeks after initiation of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to negative culture conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Treatment outcome including Cure, Treatment completion, Treatment failure, Death, Loss of follow-up, Unknown
Endpoint domain: Mortality/survival
Primary endpoint: Shared decision making
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care